Skip to main content
Publish date:

QPCR Instruments Market Size Worth $1.39 Billion By 2028: Grand View Research, Inc.

SAN FRANCISCO, Oct. 25, 2021 /PRNewswire/ -- The global qPCR instruments market  size is expected to reach USD 1.

SAN FRANCISCO, Oct. 25, 2021 /PRNewswire/ -- The global qPCR instruments market  size is expected to reach USD 1.39 billion by 2028, according to a new report by Grand View Research, Inc.It is expected to expand at a CAGR of 3.4% from 2021 to 2028.The market is driven by the introduction of novel advanced products and an increase in demand for highly efficient diagnostic equipment.

The demand for qPCR instruments and consumables is being driven by the spike in the incidence of SARS-CoV-2 infections globally. The rise in the incidence is expected to add to the number of preventive screenings. This can be attributed to the fact that nations cannot determine the number of COVID-19 patients without screening them.

Key Insights & Findings:

  • By instrument, the GeneXpert segment is expected to exhibit the fastest CAGR from 2021 to 2028
  • Asia Pacific is expected to witness the fastest growth over the forecast period due to the increasing number of investments aimed at improving diagnostic infrastructure and the growing prevalence of infectious diseases
  • Unmet needs in the market are high. For instance, the lack of affordable qPCR instruments is keeping the market from reaching its full potential
  • Newly launched products such as QuantStudio 5 Dx Real-Time PCR System provide consumers with improved workflows and high-volume testing to provide faster results. Cost-effectiveness and software that are simplified give it additional advantages
  • North America captured the largest revenue share in 2020 and is expected to maintain its lead over the forecast period. Improving regulatory support and increasing launches of novel products are anticipated to fuel the market growth

Read 109 page market research report, " qPCR Instruments Market Size, Share & Trends Analysis Report By Instrument (GeneXpert, BioFireFilmArray Systems, BMS Mic System), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2021 - 2028 ", by Grand View Research

The miniaturization of three basic molecular assays is expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to improve the availability of POC molecular diagnostic tests to yield quick and effective test results. For instance, the Mic qPCR system by Biomolecular Systems weighs only 2 kilograms, making the device highly portable and easy to handle.

Newly launched products such as QuantStudio 5 Dx Real-Time PCR System provide consumers with improved workflows and high-volume testing to provide faster results. Cost-effectiveness and software that are simplified give it additional advantages. Furthermore, the approval of the instrument in over 50 countries can help strengthen the market growth. The instrument is also equipped with measures for research companion diagnostics, giving it a competitive edge.

The market has a high threat of external substitutes owing to the presence of digital PCR instruments that are highly advanced and more accurate. The strong threat of internal substitution can be attributed to the presence of numerous products available in the market. However, the higher price of these instruments is anticipated to reduce the overall threat, keeping it at a moderate level.

COVID-19 has increased opportunities for diagnostic devices. However, advanced PCR technologies, such as dPCR, are preferred more in developed economies as they can help reduce false-positive rates. The research on developing efficient qPCR instruments can reduce the threat of substitution of devices and improve market growth.

Over recent years, PCR has witnessed technological advancements in terms of sensitivity, accuracy, efficiency, and cost-effectiveness. Key players are introducing novel technologies to maintain a competitive edge.

Grand View Research has segmented the global qPCR instruments market based on instrument and region:

  • qPCR Instruments Outlook (Revenue, USD Million, 2017 - 2028)
    • 7500
    • QuantStudioDx Real-Time PCR System
    • QuantStudio 5 Real-Time PCR System
    • ViiA 7 Dx
    • StepOne/ StepOne Plus
    • LightCycler 2.0/ 96/ 480/ 1536
    • Cobas 4800
    • CFX96
    • SmartCycler
    • GeneXpert
    • Rotor-Gene Q 5Plex HRM System
    • Rotor-Gene Q
    • BioFire FilmArray Systems
    • BMS Mic System
  • qPCR Instruments Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Brazil
      • Mexico
    • Middle East & Africa
      • South Africa
      • UAE

Key Players of qPCR Instruments Market

  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Qiagen
  • Agilent Technologies, Inc.
  • Abbott
  • bioMerieux SA
  • Quantabio
  • Azure Biosystems, Inc.
  • Bio Molecular Systems

Check out more studies on topics related Real-time PCR, conducted by Grand View Research:

  • Real-time PCR & Digital PCR Market - The global Real-time PCR (qPCR) and Digital PCR (dPCR) market size were valued at USD 2.25 billion in 2018. It is expected to expand at a CAGR of 8.5% during the forecast period. High prevalence of target diseases and rapid technological advancements such as the development of high performance and superior qPCR and dPCR systems are expected to be the key factors driving the growth.
  • qPCR Assay Market - The global qPCR assay market is expected to grow during the forecast period due to increase intervention of the government with regards to funding for research and development activities coupled with rising R&D activities in proteomics and genomics along with advancement in technology.
  • Europe Real Time PCR Market - The European Real-time Polymerase Chain Reaction (qPCR) market was valued at over USD 182 million in 2014. Key drivers encouraging market growth include rising prevalence of infectious diseases, cancer, cardiometabolic disorders, and growing geriatric population base.

Browse through Grand View Research's coverage of the Global Clinical Diagnostics Industry

Gain access to Grand View Compass , our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Web: https://www.grandviewresearch.com Follow Us: LinkedIn | Twitter 

View original content: https://www.prnewswire.com/news-releases/qpcr-instruments-market-size-worth-1-39-billion-by-2028-grand-view-research-inc-301407338.html

SOURCE Grand View Research, Inc.